Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 5th edition, 486 pages

Free download


  Breast Cancer

  Free Subscription


Articles published in Cancer Epidemiol Biomarkers Prev

Retrieve available abstracts of 103 articles:
HTML format



Single Articles


    November 2020
  1. FARVID MS, Tamimi RM, Poole EM, Chen WY, et al
    Post-diagnostic dietary glycemic index, glycemic load, dietary insulin index, and insulin load and breast cancer survival.
    Cancer Epidemiol Biomarkers Prev. 2020 Nov 20. pii: 1055-9965.EPI-20-0764.
    PubMed     Abstract available


  2. WONG ATY, Fensom GK, Key TJ, Onland-Moret NC, et al
    Urinary melatonin in relation to breast cancer risk: nested case-control analysis in the DOM study and meta-analysis of prospective studies.
    Cancer Epidemiol Biomarkers Prev. 2020 Nov 3. pii: 1055-9965.EPI-20-0822.
    PubMed     Abstract available


    October 2020
  3. MCDOUGALL JA, Cook LS, Tang MC, Thompson B, et al
    Determinants of Guideline-Discordant Breast Cancer Care.
    Cancer Epidemiol Biomarkers Prev. 2020 Oct 22. pii: 1055-9965.EPI-20-0985.
    PubMed     Abstract available


  4. PATULEIA SIS, Hagenaars SC, Moelans CB, Ausems MGEM, et al
    Lessons learned from setting up a prospective, longitudinal, multicenter study with women at high risk for breast cancer.
    Cancer Epidemiol Biomarkers Prev. 2020 Oct 20. pii: 1055-9965.EPI-20-0770.
    PubMed     Abstract available


  5. COLLIN LJ, Gaglioti AH, Beyer KMM, Zhou Y, et al
    Neighborhood-level redlining and lending bias are associated with breast cancer mortality in a large and diverse metropolitan area.
    Cancer Epidemiol Biomarkers Prev. 2020 Oct 2. pii: 1055-9965.EPI-20-1038.
    PubMed     Abstract available


    September 2020
  6. HOUGHTON LC, Howland RE, Wei Y, Ma X, et al
    The steroid metabolome and breast cancer risk in women with a family history of breast cancer: the novel role of adrenal androgens and glucocorticoids.
    Cancer Epidemiol Biomarkers Prev. 2020 Sep 30. pii: 1055-9965.EPI-20-0471.
    PubMed     Abstract available


  7. RAUF F, Anderson KS, LaBaer J
    Autoantibodies in early detection of breast cancer.
    Cancer Epidemiol Biomarkers Prev. 2020 Sep 29. pii: 1055-9965.EPI-20-0331.
    PubMed     Abstract available


  8. PHILLIPS SM, Welch WA, Fanning J, Santa-Maria CA, et al
    Daily Physical Activity and Symptom Reporting in Breast Cancer Patients Undergoing Chemotherapy: An Intensive Longitudinal Examination.
    Cancer Epidemiol Biomarkers Prev. 2020 Sep 29. pii: 1055-9965.EPI-20-0659.
    PubMed     Abstract available


  9. KENSLER KH, Liu EZF, Wetstein SC, Onken AM, et al
    Automated Quantitative Measures of Terminal Duct Lobular Unit Involution and Breast Cancer Risk.
    Cancer Epidemiol Biomarkers Prev. 2020 Sep 11. pii: 1055-9965.EPI-20-0723.
    PubMed     Abstract available


  10. SANTALA EEE, Murto MO, Artama M, Pukkala E, et al
    Angiotensin Receptor Blockers Associated with Improved Breast Cancer Survival-A Nationwide Cohort Study from Finland.
    Cancer Epidemiol Biomarkers Prev. 2020 Sep 11. pii: 1055-9965.EPI-20-0711.
    PubMed     Abstract available


    August 2020
  11. PURRINGTON KS, Raychaudhuri S, Simon MS, Clark J, et al
    Heritable susceptibility to breast cancer among African American women in the Detroit Research on Cancer Survivors Study.
    Cancer Epidemiol Biomarkers Prev. 2020 Aug 31. pii: 1055-9965.EPI-20-0564.
    PubMed     Abstract available


  12. SAUDER CAM, Li Q, Othieno A, Cruz D, et al
    Characteristics and Outcomes for Secondary Breast Cancer in Childhood, Adolescent, and Young Adult Cancer Survivors Treated with Radiation.
    Cancer Epidemiol Biomarkers Prev. 2020 Aug 26. pii: 1055-9965.EPI-20-0260.
    PubMed     Abstract available


  13. MCCULLOUGH ML, Gapstur SM, Gaudet MM, Wang Y, et al
    Coffee Consumption and Invasive Breast Cancer Incidence among Postmenopausal Women in the Cancer Prevention Study II Nutrition Cohort.
    Cancer Epidemiol Biomarkers Prev. 2020 Aug 14. pii: 1055-9965.EPI-20-1051.
    PubMed     Abstract available


  14. GAGLIARDI A, Dugue PA, Nost TH, Southey MC, et al
    Stochastic epigenetic mutations are associated with risk of breast cancer, lung cancer and mature B-cell neoplasms.
    Cancer Epidemiol Biomarkers Prev. 2020 Aug 11. pii: 1055-9965.EPI-20-0451.
    PubMed     Abstract available


  15. HWANG KT, Han KD, Oh S, Koo BK, et al
    Influence of Metabolic Syndrome on Risk of Breast Cancer: A Study Analyzing Nationwide Data from Korean National Health Insurance Service.
    Cancer Epidemiol Biomarkers Prev. 2020 Aug 6. pii: 1055-9965.EPI-20-0300.
    PubMed     Abstract available


    July 2020
  16. BISSELL MCS, Kerlikowske K, Sprague BL, Tice JA, et al
    Breast Cancer Population Attributable Risk Proportions Associated with Body Mass Index and Breast Density by Race/Ethnicity and Menopausal Status.
    Cancer Epidemiol Biomarkers Prev. 2020 Jul 29. pii: 1055-9965.EPI-20-0358.
    PubMed     Abstract available


  17. REDING KW, Han CJ, Whittington D, Zahid M, et al
    Risk of breast cancer associated with estrogen DNA adduct biomarker.
    Cancer Epidemiol Biomarkers Prev. 2020 Jul 22. pii: 1055-9965.EPI-20-0133.
    PubMed     Abstract available


  18. HIATT RA, Engmann NJ, Balke K, Rehkopf DH, et al
    A Complex Systems Model of Breast Cancer Etiology: The Paradigm II Conceptual Model.
    Cancer Epidemiol Biomarkers Prev. 2020 Jul 8. pii: 1055-9965.EPI-20-0016.
    PubMed     Abstract available


  19. LANGE M, Hardy-Leger I, Licaj I, Pistilli B, et al
    Cognitive impairment in breast cancer patients before surgery: results from a CANTO cohort subgroup.
    Cancer Epidemiol Biomarkers Prev. 2020 Jul 1. pii: 1055-9965.EPI-20-0346.
    PubMed     Abstract available


    May 2020
  20. MANJER J, Sandsveden M, Borgquist S
    Serum iodine and breast cancer risk: A prospective nested case-control study stratified for selenium levels.
    Cancer Epidemiol Biomarkers Prev. 2020 May 26. pii: 1055-9965.EPI-20-0122.
    PubMed     Abstract available


    April 2020
  21. BERTRAND KA, Castro-Webb N, Cozier YC, Li S, et al
    Gestational diabetes and risk of breast cancer in African American women.
    Cancer Epidemiol Biomarkers Prev. 2020 Apr 21. pii: 1055-9965.EPI-20-0034.
    PubMed     Abstract available


  22. YOO TK, Han KD, Kim D, Ahn J, et al
    Hormone replacement therapy, breast cancer risk factors and breast cancer risk: a nationwide population-based cohort.
    Cancer Epidemiol Biomarkers Prev. 2020 Apr 16. pii: 1055-9965.EPI-20-0038.
    PubMed     Abstract available


  23. KENZIK KM, Rocque GB, Landier W, Bhatia S, et al
    Urban vs. rural residence and outcomes in older breast cancer patients.
    Cancer Epidemiol Biomarkers Prev. 2020 Apr 16. pii: 1055-9965.EPI-19-1414.
    PubMed     Abstract available


  24. BEFORT CA, Kimler BF, Bantis LE, Phillips TA, et al
    Effects of Weight Loss and Weight Regain on Circulating Biomarkers in Overweight/Obese Breast Cancer Survivors Enrolled in a Weight Loss Trial in the Rural Midwest.
    Cancer Epidemiol Biomarkers Prev. 2020 Apr 10. pii: 1055-9965.EPI-19-1572.
    PubMed     Abstract available


  25. KOTSOPOULOS J, McGee EE, Lozano-Esparza S, Garber JE, et al
    Premenopausal plasma osteoprotegerin and breast cancer risk: a case-control analysis nested within the Nurses' Health Study II.
    Cancer Epidemiol Biomarkers Prev. 2020 Apr 10. pii: 1055-9965.EPI-19-1154.
    PubMed     Abstract available


  26. JEE YH, Gao C, Kim J, Park S, et al
    Validating breast-cancer risk prediction models in the Korean Cancer Prevention Study-II Biobank.
    Cancer Epidemiol Biomarkers Prev. 2020 Apr 3. pii: 1055-9965.EPI-19-1478.
    PubMed     Abstract available


  27. PENG C, Heng YJ, Lu D, DuPre NC, et al
    Pre-diagnostic 25-hydroxyvitamin D concentrations in relation to tumor molecular alterations and risk of breast cancer recurrence.
    Cancer Epidemiol Biomarkers Prev. 2020 Apr 1. pii: 1055-9965.EPI-19-1217.
    PubMed     Abstract available


  28. GEARHART-SERNA LM, Hoffman K, Devi GR
    Environmental Quality and Invasive Breast Cancer.
    Cancer Epidemiol Biomarkers Prev. 2020 Apr 1. pii: 1055-9965.EPI-19-1497.
    PubMed     Abstract available


    March 2020
  29. LE MARCHAND L, Wilkens LR, Castelfranco AM, Monroe KR, et al
    Circulating Biomarker Score for Visceral Fat and Risks of Incident Colorectal and Postmenopausal Breast Cancer: The Multiethnic Cohort Adiposity Phenotype Study.
    Cancer Epidemiol Biomarkers Prev. 2020 Mar 4. pii: 1055-9965.EPI-19-1469.
    PubMed     Abstract available


  30. TANGKA FKL, Subramanian S, Jones M, Edwards P, et al
    Insurance Coverage, Employment Status, and Financial Well-Being of Young Women Diagnosed with Breast Cancer.
    Cancer Epidemiol Biomarkers Prev. 2020;29:616-624.
    PubMed     Abstract available


  31. SAMAYOA C, Santoyo-Olsson J, Escalera C, Stewart AL, et al
    Participant-Centered Strategies for Overcoming Barriers to Biospecimen Collection among Spanish-Speaking Latina Breast Cancer Survivors.
    Cancer Epidemiol Biomarkers Prev. 2020;29:606-615.
    PubMed     Abstract available


    January 2020
  32. GABRIELSON M, Ubhayaseker KA, Acharya SR, Andersson Franko M, et al
    Inclusion of endogenous plasma dehydroepiandrosterone sulphate and mammographic density in risk prediction models for breast cancer.
    Cancer Epidemiol Biomarkers Prev. 2020 Jan 16. pii: 1055-9965.EPI-19-1120.
    PubMed     Abstract available


  33. AHERN TP, Collin LJ, Baurley JW, Kjaersgaard A, et al
    Metabolic pathway analysis and effectiveness of tamoxifen in Danish breast cancer patients.
    Cancer Epidemiol Biomarkers Prev. 2020 Jan 13. pii: 1055-9965.EPI-19-0833.
    PubMed     Abstract available


  34. HENG YJ, Hankinson SE, Wang J, Alexandrov LB, et al
    The association of modifiable breast cancer risk factors and somatic genomic alterations in breast tumors: The Cancer Genome Atlas Network.
    Cancer Epidemiol Biomarkers Prev. 2020 Jan 13. pii: 1055-9965.EPI-19-1087.
    PubMed     Abstract available


  35. SWEENEY MR, Sandler DP, Niehoff NM, White AJ, et al
    Shift work and working at night in relation to breast cancer incidence.
    Cancer Epidemiol Biomarkers Prev. 2020 Jan 8. pii: 1055-9965.EPI-19-1314.
    PubMed     Abstract available


  36. XING CY, Doose M, Qin B, Lin Y, et al
    Prediagnostic Allostatic Load as a Predictor of Poorly Differentiated and Larger Sized Breast Cancers among Black Women in the Women's Circle of Health Follow-Up Study.
    Cancer Epidemiol Biomarkers Prev. 2020;29:216-224.
    PubMed     Abstract available


    December 2019
  37. CHENG TD, Yao S, Omilian AR, Khoury T, et al
    FOXA1 protein expression in ER+ and ER- breast cancer in relation to parity and breastfeeding in Black and White women.
    Cancer Epidemiol Biomarkers Prev. 2019 Dec 23. pii: 1055-9965.EPI-19-0787.
    PubMed     Abstract available


  38. ADEDOKUN B, Zheng Y, Ndom P, Gakwaya A, et al
    Prevalence of Inherited Mutations in Breast Cancer Predisposition Genes among Uganda and Cameroon Women.
    Cancer Epidemiol Biomarkers Prev. 2019 Dec 23. pii: 1055-9965.EPI-19-0506.
    PubMed     Abstract available


  39. HSU CD, Peacock Hinton S, Reeder-Hayes KE, Sanoff HK, et al
    Association between concomitant use of hydrochlorothiazide and adverse chemotherapy-related events among older women with breast cancer treated with cyclophosphamide.
    Cancer Epidemiol Biomarkers Prev. 2019 Dec 23. pii: 1055-9965.EPI-19-1079.
    PubMed     Abstract available


  40. WANG F, Cai H, Gu K, Shi L, et al
    Adherence to Dietary Recommendations Among Long-Term Breast Cancer Survivors and Cancer Outcome Associations.
    Cancer Epidemiol Biomarkers Prev. 2019 Dec 23. pii: 1055-9965.EPI-19-0872.
    PubMed     Abstract available


  41. LI H, Terry MB, Antoniou AC, Phillips KA, et al
    Alcohol consumption, cigarette smoking, and risk of breast cancer for BRCA1 and BRCA2 mutation carriers: results from The BRCA1 and BRCA2 Cohort Consortium.
    Cancer Epidemiol Biomarkers Prev. 2019 Dec 2. pii: 1055-9965.EPI-19-0546.
    PubMed     Abstract available


    November 2019
  42. LECUYER L, Dalle C, Lefevre-Arbogast S, Micheau P, et al
    Diet-related metabolomic signature of long-term breast cancer risk using penalized regression: an exploratory study in the SU.VI.MAX cohort.
    Cancer Epidemiol Biomarkers Prev. 2019 Nov 25. pii: 1055-9965.EPI-19-0900.
    PubMed     Abstract available


  43. GEORGE A, Sturgeon SR, Hankinson SE, Shadyab AH, et al
    Psychotropic medication use and postmenopausal breast cancer risk.
    Cancer Epidemiol Biomarkers Prev. 2019 Nov 4. pii: 1055-9965.EPI-19-0776.
    PubMed     Abstract available


    October 2019
  44. KINNUNEN PT, Murto MO, Artama M, Pukkala E, et al
    Anticoagulants and breast cancer survival, a nationwide cohort study.
    Cancer Epidemiol Biomarkers Prev. 2019 Oct 25. pii: 1055-9965.EPI-19-0147.
    PubMed     Abstract available


  45. WIESE D, Stroup AM, Crosbie A, Lynch SM, et al
    The Impact of Neighborhood Economic and Racial Inequalities on the Spatial Variation of Breast Cancer Survival in New Jersey.
    Cancer Epidemiol Biomarkers Prev. 2019 Oct 24. pii: 1055-9965.EPI-19-0416.
    PubMed     Abstract available


    September 2019
  46. GUAN A, Lichtensztajn DY, Oh D, Jain J, et al
    Breast Cancer in San Francisco: Disentangling Disparities at the Neighborhood Level.
    Cancer Epidemiol Biomarkers Prev. 2019 Sep 23. pii: 1055-9965.EPI-19-0799.
    PubMed     Abstract available


  47. GULERIA S, Kjaer SK, Albieri V, Frederiksen K, et al
    A cohort study of breast cancer risk after 20 years of follow-up of women treated with fertility drugs.
    Cancer Epidemiol Biomarkers Prev. 2019 Sep 18. pii: 1055-9965.EPI-19-0652.
    PubMed     Abstract available


  48. DENG L, Lu D, Bai Y, Wang YP, et al
    Immune Profiles of Tumor Microenvironment and Clinical Prognosis among Women with Triple-Negative Breast Cancer.
    Cancer Epidemiol Biomarkers Prev. 2019 Sep 18. pii: 1055-9965.EPI-19-0469.
    PubMed     Abstract available


  49. JOHN EM, Canchola AJ, Sanagaramoorthy M, Koo J, et al
    Race/ethnicity and accuracy of self-reported female first-degree family history of breast and other cancers in the Northern California Breast Cancer Family Registry.
    Cancer Epidemiol Biomarkers Prev. 2019 Sep 5. pii: 1055-9965.EPI-19-0444.
    PubMed     Abstract available


    August 2019
  50. REY-VARGAS L, Sanabria Salas MC, Fejerman L, Serrano-Gomez SJ, et al
    Risk factors for triple negative breast cancer among Latina women.
    Cancer Epidemiol Biomarkers Prev. 2019 Aug 27. pii: 1055-9965.EPI-19-0035.
    PubMed     Abstract available


  51. STOLARZ AJ, Lakkad M, Klimberg VS, Painter JT, et al
    Calcium channel blocker and risk of lymphedema among breast cancer patients: nested case control study.
    Cancer Epidemiol Biomarkers Prev. 2019 Aug 9. pii: 1055-9965.EPI-19-0448.
    PubMed     Abstract available


  52. BENEFIELD HC, Zabor EC, Shan Y, Allott EH, et al
    Evidence for etiologic subtypes of breast cancer in the Carolina Breast Cancer Study.
    Cancer Epidemiol Biomarkers Prev. 2019 Aug 8. pii: 1055-9965.EPI-19-0365.
    PubMed     Abstract available


  53. CHEN H, Cook LS, Tang MC, Hill DA, et al
    Relationship between diabetes and diabetes medications and risk of different molecular subtypes of breast cancer.
    Cancer Epidemiol Biomarkers Prev. 2019 Aug 8. pii: 1055-9965.EPI-19-0291.
    PubMed     Abstract available


  54. FRIEDENREICH CM, Wang Q, Yasui Y, Stanczyk FZ, et al
    Long-term effects of moderate versus high durations of aerobic exercise on biomarkers of breast cancer risk: Follow-up to a randomized controlled trial.
    Cancer Epidemiol Biomarkers Prev. 2019 Aug 5. pii: 1055-9965.EPI-19-0523.
    PubMed     Abstract available


    July 2019
  55. BOOMS A, Coetzee GA, Pierce SE
    MCF-7 as a model for functional analysis of breast cancer risk variants.
    Cancer Epidemiol Biomarkers Prev. 2019 Jul 10. pii: 1055-9965.EPI-19-0066.
    PubMed     Abstract available


  56. PETRIDIS C, Arora I, Shah V, Moss CL, et al
    Frequency of Pathogenic Germline Variants in CDH1, BRCA2, CHEK2, PALB2, BRCA1, and TP53 in Sporadic Lobular Breast Cancer.
    Cancer Epidemiol Biomarkers Prev. 2019;28:1162-1168.
    PubMed     Abstract available


    June 2019
  57. NATARAJAN L, Pu M, Davies SR, Vickery TL, et al
    MiRNAs and long-term breast cancer survival: Evidence from the WHEL Study.
    Cancer Epidemiol Biomarkers Prev. 2019 Jun 11. pii: 1055-9965.EPI-18-1322.
    PubMed     Abstract available


  58. LECUYER L, Dalle C, Lyan B, Demidem A, et al
    Plasma metabolomic signatures associated with long-term breast cancer risk in the SU.VI.MAX prospective cohort.
    Cancer Epidemiol Biomarkers Prev. 2019 Jun 4. pii: 1055-9965.EPI-19-0154.
    PubMed     Abstract available


  59. GUO X, Lin W, Bai M, Li H, et al
    Discovery of a pathogenic variant rs139379666 (p. P2974L) in ATM for breast cancer risk in Chinese populations.
    Cancer Epidemiol Biomarkers Prev. 2019 Jun 3. pii: 1055-9965.EPI-18-1294.
    PubMed     Abstract available


    April 2019
  60. JUNG SY, Jung KW, Ha J, Won YJ, et al
    Different Patterns of Conditional Survival of Breast Cancer Patients by Age and Histologic types: Evidence from the Korean Nationwide Registry.
    Cancer Epidemiol Biomarkers Prev. 2019 Apr 26. pii: 1055-9965.EPI-18-1072.
    PubMed     Abstract available


  61. VISSER LL, Groen EJ, van Leeuwen FE, Lips EH, et al
    Predictors of an Invasive Breast Cancer Recurrence after DCIS: A Systematic Review and Meta-analyses.
    Cancer Epidemiol Biomarkers Prev. 2019 Apr 25. pii: 1055-9965.EPI-18-0976.
    PubMed     Abstract available


  62. GLYNN RJ, Colditz GA, Tamimi RM, Chen WY, et al
    Comparison of questionnaire-based breast cancer prediction models in the Nurses' Health Study.
    Cancer Epidemiol Biomarkers Prev. 2019 Apr 23. pii: 1055-9965.EPI-18-1039.
    PubMed     Abstract available


    March 2019
  63. KJAERULFF TM, Ersboll AK, Green A, Emneus M, et al
    Finasteride use and risk of male breast cancer: a case-control study using individual-level registry data from Denmark, Finland, and Sweden.
    Cancer Epidemiol Biomarkers Prev. 2019 Mar 6. pii: 1055-9965.EPI-18-0904.
    PubMed     Abstract available


    January 2019
  64. DUPRE NC, Hart JE, Holmes MD, Poole EM, et al
    Particulate Matter and Traffic-related Exposures in Relation to Breast Cancer Survival.
    Cancer Epidemiol Biomarkers Prev. 2019 Jan 15. pii: 1055-9965.EPI-18-0803.
    PubMed     Abstract available


  65. DECKER B, Allen J, Luccarini C, Pooley KA, et al
    Targeted resequencing of the coding sequence of 38 genes near breast cancer GWAS loci in a large case-control study.
    Cancer Epidemiol Biomarkers Prev. 2019 Jan 14. pii: 1055-9965.EPI-18-0298.
    PubMed     Abstract available


    December 2018
  66. FUNG SM, Wong XY, Lee SX, Miao H, et al
    Performance of Single Nucleotide Polymorphisms in Breast Cancer Risk Prediction Models: A Systematic Review and Meta-analysis.
    Cancer Epidemiol Biomarkers Prev. 2018 Dec 18. pii: 1055-9965.EPI-18-0810.
    PubMed     Abstract available


  67. BOLF EL, Sprague BL, Carr FE
    A Linkage Between Thyroid and Breast Cancer: A Common Etiology?
    Cancer Epidemiol Biomarkers Prev. 2018 Dec 12. pii: 1055-9965.EPI-18-0877.
    PubMed     Abstract available


    November 2018
  68. XIE J, Xu Z
    A Population-Based Study on Liver Metastases in Women With Newly Diagnosed Breast Cancer.
    Cancer Epidemiol Biomarkers Prev. 2018 Nov 28. pii: 1055-9965.EPI-18-0591.
    PubMed     Abstract available


  69. GUAN Z, Yu H, Cuk K, Zhang Y, et al
    Whole-blood DNA methylation markers in early detection of breast cancer: a systematic literature review.
    Cancer Epidemiol Biomarkers Prev. 2018 Nov 28. pii: 1055-9965.EPI-18-0378.
    PubMed     Abstract available


  70. MORMILE R
    Metformin Therapy and Breast Cancer Incidence and Mortality-Letter.
    Cancer Epidemiol Biomarkers Prev. 2018;27:1384.
    PubMed    


    October 2018
  71. MOEN EL, Kapadia NS, O'Malley AJ, Onega T, et al
    Evaluating breast cancer care coordination at a rural National Cancer Institute Comprehensive Cancer Center using network analysis and geospatial methods.
    Cancer Epidemiol Biomarkers Prev. 2018 Oct 30. pii: 1055-9965.EPI-18-0771.
    PubMed     Abstract available


  72. MARIOTTO AB, Zou Z, Zhang F, Howlader N, et al
    Can We Use Survival Data from Cancer Registries to Learn about Disease Recurrence? The Case of Breast Cancer.
    Cancer Epidemiol Biomarkers Prev. 2018 Oct 18. pii: 1055-9965.EPI-17-1129.
    PubMed     Abstract available


  73. TAO L, Schwab RB, San Miguel Y, Gomez SL, et al
    Breast Cancer Mortality in Older and Younger Breast Cancer Patients in California.
    Cancer Epidemiol Biomarkers Prev. 2018 Oct 17. pii: 1055-9965.EPI-18-0353.
    PubMed     Abstract available


  74. NIEHOFF NM, Nichols HB, Zhao S, White AJ, et al
    Adult physical activity and breast cancer risk in women with a family history of breast cancer.
    Cancer Epidemiol Biomarkers Prev. 2018 Oct 17. pii: 1055-9965.EPI-18-0674.
    PubMed     Abstract available


    September 2018
  75. GUINTER MA, Sandler DP, McLain AC, Merchant AT, et al
    An Estrogen-Related Dietary Pattern and Postmenopausal Breast Cancer Risk in a Cohort of Women with a Family History of Breast Cancer.
    Cancer Epidemiol Biomarkers Prev. 2018 Sep 19. pii: 1055-9965.EPI-18-0514.
    PubMed     Abstract available


  76. BOND-SMITH D, Stone J
    Methodological challenges and updated findings from a meta-analysis of the association between mammographic density and breast cancer.
    Cancer Epidemiol Biomarkers Prev. 2018 Sep 11. pii: 1055-9965.EPI-17-1175.
    PubMed     Abstract available


    August 2018
  77. PFEIFFER RM, Webb-Vargas Y, Wheeler W, Gail MH, et al
    Proportion of U.S. Trends in Breast Cancer Incidence Attributable to Long-term Changes in Risk Factor Distributions.
    Cancer Epidemiol Biomarkers Prev. 2018 Aug 1. pii: 1055-9965.EPI-18-0098.
    PubMed     Abstract available


    July 2018
  78. BOYNE DJ, O'Sullivan DE, Olij BF, King WD, et al
    Physical Activity, Global DNA Methylation and Breast Cancer Risk: A Systematic Literature Review and Meta-Analysis.
    Cancer Epidemiol Biomarkers Prev. 2018 Jul 10. pii: 1055-9965.EPI-18-0175.
    PubMed     Abstract available


  79. BERGIN RJ, Emery J, Bollard RC, Falborg AZ, et al
    Rural-urban disparities in time to diagnosis and treatment for colorectal and breast cancer.
    Cancer Epidemiol Biomarkers Prev. 2018 Jul 9. pii: 1055-9965.EPI-18-0210.
    PubMed     Abstract available


    June 2018
  80. HJERKIND KV, Ellingjord-Dale M, Johansson ALV, Aase HS, et al
    Volumetric mammographic density, age-related decline, and breast cancer risk factors in a national breast cancer screening program.
    Cancer Epidemiol Biomarkers Prev. 2018 Jun 20. pii: 1055-9965.EPI-18-0151.
    PubMed     Abstract available


  81. SCANNELL BRYAN M, Argos M, Andrulis IL, Hopper JL, et al
    Germline variation and breast cancer incidence: A gene-based association study and whole-genome prediction of early onset breast cancer.
    Cancer Epidemiol Biomarkers Prev. 2018 Jun 13. pii: 1055-9965.EPI-17-1185.
    PubMed     Abstract available


    May 2018
  82. PARL FF, Crooke PS, Plummer WD, Dupont WD, et al
    Genomic-Epidemiologic Evidence that Estrogens Promote Breast Cancer Development.
    Cancer Epidemiol Biomarkers Prev. 2018 May 22. pii: 1055-9965.EPI-17-1174.
    PubMed     Abstract available


  83. FARVID MS, Eliassen AH, Cho E, Chen WY, et al
    Dairy Consumption in Adolescence and Early Adulthood and Risk of Breast Cancer.
    Cancer Epidemiol Biomarkers Prev. 2018;27:575-584.
    PubMed     Abstract available


    April 2018
  84. WANG S, Ogundiran TO, Ademola A, Oluwasola OA, et al
    Development of a Breast Cancer Risk Prediction Model for Women in Nigeria.
    Cancer Epidemiol Biomarkers Prev. 2018 Apr 20. pii: 1055-9965.EPI-17-1128.
    PubMed     Abstract available


  85. MADSEN MJ, Knight S, Sweeney C, Factor RE, et al
    Reparameterization of PAM50 expression identifies novel breast tumor dimensions and leads to discovery of a genomewide significant breast cancer locus at 12q15.
    Cancer Epidemiol Biomarkers Prev. 2018 Apr 12. pii: 1055-9965.EPI-17-0887.
    PubMed     Abstract available


  86. TANG GH, Satkunam M, Pond GR, Steinberg GR, et al
    Association of metformin with breast cancer incidence and mortality in patients with type 2 diabetes: a GRADE assessed systematic review and meta-analysis.
    Cancer Epidemiol Biomarkers Prev. 2018 Apr 4. pii: 1055-9965.EPI-17-0936.
    PubMed     Abstract available


    March 2018
  87. HOWLADER N, Cronin KA, Kurian AW, Andridge R, et al
    Differences in Breast Cancer Survival by Molecular Subtypes in the United States.
    Cancer Epidemiol Biomarkers Prev. 2018 Mar 28. pii: 1055-9965.EPI-17-0627.
    PubMed     Abstract available


  88. BRANTLEY KD, Kjaersgaard A, Cronin-Fenton D, Yacoub R, et al
    Stanniocalcin expression as a predictor of late breast cancer recurrence.
    Cancer Epidemiol Biomarkers Prev. 2018 Mar 28. pii: 1055-9965.EPI-17-0905.
    PubMed     Abstract available


    January 2018
  89. LILYQUIST J, Ruddy KJ, Vachon CM, Couch FJ, et al
    Common Genetic Variation and Breast Cancer Risk - Past, present, and future.
    Cancer Epidemiol Biomarkers Prev. 2018 Jan 30. pii: 1055-9965.EPI-17-1144.
    PubMed     Abstract available


  90. ZHENG J, Tabung FK, Zhang J, Liese AD, et al
    Association between post-cancer diagnosis dietary inflammatory potential and mortality among invasive breast cancer survivors in the Women's Health Initiative.
    Cancer Epidemiol Biomarkers Prev. 2018 Jan 22. pii: 1055-9965.EPI-17-0569.
    PubMed     Abstract available


  91. HONG CC, Sucheston-Campbell LE, Liu S, Hu Q, et al
    Genetic variants in immune-related pathways and breast cancer risk in African American women in the AMBER consortium.
    Cancer Epidemiol Biomarkers Prev. 2018 Jan 16. pii: 1055-9965.EPI-17-0434.
    PubMed     Abstract available


  92. BAGLIA ML, Tang MC, Malone KE, Porter P, et al
    Family History and Risk of Second Primary Breast Cancer after In Situ Breast Carcinoma.
    Cancer Epidemiol Biomarkers Prev. 2018 Jan 16. pii: 1055-9965.EPI-17-0837.
    PubMed     Abstract available


    December 2017
  93. REEVES KW, Okereke OI, Qian J, Tamimi RM, et al
    Depression, antidepressant use and breast cancer risk in pre- and postmenopausal women: a prospective cohort study.
    Cancer Epidemiol Biomarkers Prev. 2017 Dec 20. pii: 1055-9965.EPI-17-0707.
    PubMed     Abstract available


  94. WANG S, Zheng Y, Ogundiran TO, Ojengbede O, et al
    Association of Pancreatic Cancer Susceptibility Variants with Risk of Breast Cancer in Women of European and African Ancestry.
    Cancer Epidemiol Biomarkers Prev. 2017 Dec 18. pii: 1055-9965.EPI-17-0755.
    PubMed     Abstract available


  95. MALONE KE, Korde LA, Doody DR, Hsu L, et al
    Bisphosphonate use and risk of recurrence, second primary breast cancer, and breast cancer mortality in a population-based cohort of breast cancer patients.
    Cancer Epidemiol Biomarkers Prev. 2017 Dec 18. pii: 1055-9965.EPI-17-0556.
    PubMed     Abstract available


    November 2017
  96. WINTERS-STONE K, Wood LJ, Stoyles S, Dieckmann N, et al
    The Effects of Resistance Exercise on Biomarkers of Breast Cancer Prognosis: A Pooled Analysis of Three Randomized Trials.
    Cancer Epidemiol Biomarkers Prev. 2017 Nov 15. pii: cebp.0766.2017.
    PubMed     Abstract available


  97. SHAO S, Gill AA, Zahm SH, Jatoi I, et al
    Diabetes and overall survival among breast cancer patients in the US military health system.
    Cancer Epidemiol Biomarkers Prev. 2017 Nov 2. pii: cebp.0439.2017.
    PubMed     Abstract available


  98. HOWELL A, Ashcroft L, Fallowfield L, Eccles DM, et al
    RAZOR: a phase II open randomized trial of screening plus goserelin and raloxifene versus screening alone in pre-menopausal women at increased risk of breast cancer.
    Cancer Epidemiol Biomarkers Prev. 2017 Nov 2. pii: cebp.0158.2017.
    PubMed     Abstract available


    October 2017
  99. SERRANO-GOMEZ SJ, Fejerman L, Zabaleta J
    Breast cancer in Latinas: a focus on intrinsic subtypes distribution.
    Cancer Epidemiol Biomarkers Prev. 2017 Oct 20. pii: cebp.0420.2017.
    PubMed     Abstract available


  100. SHIYANBOLA OO, Arao RF, Miglioretti DL, Sprague BL, et al
    Emerging Trends in Family History of Breast Cancer and Associated Risk.
    Cancer Epidemiol Biomarkers Prev. 2017 Oct 6. pii: cebp.0531.2017.
    PubMed     Abstract available


    September 2017
  101. DEAN LT, Moss SL, McCarthy AM, Armstrong K, et al
    Healthcare System Distrust, Physician Trust, and Patient Discordance with Adjuvant Breast Cancer Treatment Recommendations.
    Cancer Epidemiol Biomarkers Prev. 2017 Sep 29. pii: cebp.0479.2017.
    PubMed     Abstract available


  102. KABAT GC, Kim MY, Lee JS, Ho GY, et al
    Metabolic obesity phenotypes and risk of breast cancer in postmenopausal women.
    Cancer Epidemiol Biomarkers Prev. 2017 Sep 22. pii: cebp.0495.2017.
    PubMed     Abstract available


  103. HIATT RA, Stewart SL, Hoeft KS, Kushi LH, et al
    CHILDHOOD SOCIOECONOMIC POSITION AND PUBERTAL ONSET IN A COHORT OF MULTIETHNIC GIRLS: IMPLICATIONS FOR BREAST CANCER.
    Cancer Epidemiol Biomarkers Prev. 2017 Sep 22. pii: cebp.0496.2017.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: